RAPH

$1.51+0.00%visit website

Raphael Pharmaceutical Inc.

Market Cap

$30M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Medicinal Chemicals & Botanical Products

Beta (raw)

1.87

45mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	73	345	37	40	495
Operating income	(251)	(254)	(223)	(199)	(927)
Net income	(255)	(273)	(229)	(223)	(980)
EPS (basic) ($)	0.01		0.01	0.01	0.05
EPS (diluted) ($)	0.01		0.01	0.01	0.05
Weighted avg. shares (basic)	19,626		20,176	20,176
Weighted avg. shares (diluted)	19,626		20,176	20,176

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 20 more quarters, back to Sep 2020, with Tormere Pro.

Corporate Events (8-K)

3 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Sep 1, 2026 accepted 12:51 PM ET	1.01Material agreement	Document SEC ↗
Jul 17, 2026 accepted 9:20 AM ET	5.02Officer / director change	Document SEC ↗
Mar 24, 2026 accepted 4:01 PM ET	5.02Officer / director change	Document SEC ↗
Aug 11, 2025 accepted 4:05 PM ET	5.02Officer / director change	Document SEC ↗
Aug 11, 2025 accepted 7:00 AM ET	8.01Other events	Document SEC ↗
Jan 14, 2025 accepted 4:00 PM ET	5.02Officer / director change	Document SEC ↗
Dec 30, 2024 accepted 4:00 PM ET	8.01Other events	Document SEC ↗